News
7h
Zacks Investment Research on MSNVeeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationship management (CRM) market. Veeva Systems VEEV, a long-time partner of ...
2h
Zacks Investment Research on MSNSalesforce.com (CRM) Outperforms Broader Market: What You Need to KnowIn the latest trading session, Salesforce.com (CRM) closed at $267.22, marking a +1.38% move from the previous day. This move outpaced the S&P 500's daily gain of 0.78%. Elsewhere, the Dow gained 1.14 ...
Navigate mobile app development with our 2025 market map featuring leading tools across 6 essential categories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results